Insiders · NMRA

NMRA insider transactions

Neumora Therapeutics Inc. (NMRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NMRA

• 65d
  Officer Aurora Daljit Singh sold $21,917 worth of shares (6,165 units at $3.56), decreasing direct ownership by 7% to 82,770 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 65d
  President Pinto Joshua sold $21,093 worth of shares (5,967 units at $3.54), decreasing direct ownership by 9% to 57,783 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 65d
  Officer Berns Paul L sold $34,459 worth of shares (9,819 units at $3.51), decreasing direct ownership by 0.13% to 7,395,185 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 65d
  Officer Milligan Michael Lee sold $5,119 worth of shares (1,436 units at $3.56), decreasing direct ownership by 6% to 21,034 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 106d
  SEC Form 4 filed by Officer Milligan Michael Lee

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 106d
  SEC Form 4 filed by Officer Aurora Daljit Singh

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 106d
  SEC Form 4 filed by Officer Duncan Jason

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 106d
  SEC Form 4 filed by President Pinto Joshua

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 106d
  SEC Form 4 filed by Officer Berns Paul L

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 163d
  Officer Aurora Daljit Singh sold $307,026 worth of shares (114,703 units at $2.68) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 178d
  Director Burow Kristina bought $4,999,977 worth of shares (1,915,700 units at $2.61) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 178d
  Large owner Arch Venture Partners Xii, Llc bought $4,999,977 worth of shares (1,915,700 units at $2.61) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 178d
  Large owner Arch Venture Partners X, Llc bought $4,999,977 worth of shares (1,915,700 units at $2.61) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Officer Milligan Michael Lee

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Director Fust Matthew K

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Officer Duncan Jason

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Officer Aurora Daljit Singh

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Director Burow Kristina

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Director Piacquad David

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Director Ho Maykin

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Officer Berns Paul L

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by Director Halawa Alaa

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 330d
  SEC Form 4 filed by President Pinto Joshua

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 338d
  President Pinto Joshua gifted 13,202 shares and received a gift of 13,202 shares, decreasing direct ownership by 17% to 63,750 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 429d
  Officer Berns Paul L sold $23,468 worth of shares (13,871 units at $1.69), decreasing direct ownership by 0.19% to 7,405,004 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 429d
  Officer Milligan Michael Lee sold $3,351 worth of shares (1,978 units at $1.69), decreasing direct ownership by 8% to 22,470 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 429d
  Chief Strategy Officer Aurora Daljit Singh sold $14,347 worth of shares (8,565 units at $1.68), decreasing direct ownership by 9% to 88,935 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 429d
  Head of R&D Lenz Robert A. sold $9,383 worth of shares (5,614 units at $1.67), decreasing direct ownership by 2% to 309,092 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 429d
  President Pinto Joshua sold $13,477 worth of shares (8,048 units at $1.67), decreasing direct ownership by 9% to 76,952 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Director Ho Maykin

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Director Fust Matthew K

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by President Pinto Joshua

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Head of R&D Lenz Robert A.

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Officer Berns Paul L

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Officer Milligan Michael Lee

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Director Piacquad David

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Officer Aurora Daljit Singh

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Director Burow Kristina

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Director Halawa Alaa

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 431d
  SEC Form 4 filed by Officer Duncan Jason

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 484d
  Director Berns Paul L gifted 399,291 shares, decreasing direct ownership by 5% to 7,418,875 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 554d
  Director Fust Matthew K exercised 21,788 shares at a strike of $5.83 and sold $370,962 worth of shares (21,788 units at $17.03) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 562d
  Head of R&D Lenz Robert A. sold $208,110 worth of shares (13,823 units at $15.06), decreasing direct ownership by 4% to 314,706 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 584d
  Head of R&D Lenz Robert A. sold $492,827 worth of shares (41,464 units at $11.89), decreasing direct ownership by 11% to 328,529 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 587d
  Head of R&D Lenz Robert A. sold $376,665 worth of shares (32,948 units at $11.43), decreasing direct ownership by 8% to 369,993 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 589d
  SEC Form 4 filed by Chief Strategy Officer Aurora Daljit Singh

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 606d
  Chief Financial Officer Pinto Joshua sold $178,806 worth of shares (15,693 units at $11.39) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 607d
  Chief Financial Officer Pinto Joshua sold $984,061 worth of shares (84,307 units at $11.67) (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 666d
  Chief Financial Officer Pinto Joshua gifted 238,965 shares (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 681d
  Director Ho Maykin was granted 20,100 shares (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 681d
  Director Piacquad David was granted 20,100 shares (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 681d
  Director Halawa Alaa was granted 20,100 shares (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 681d
  Director Fust Matthew K was granted 20,100 shares (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 681d
  Director Burow Kristina was granted 20,100 shares, increasing direct ownership by 73% to 47,717 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)
• 731d
  Aurora Daljit Singh gifted 114,703 shares, decreasing direct ownership by 54% to 97,500 units (SEC Form 4)

  4 - Neumora Therapeutics, Inc. (0001885522) (Issuer)